N@N

49.74% Of All NASDAQ Trading Tuesday Was Short Selling. MBRX, XTXI, ISPH, LOPE, SMSI, ZBRA Highest % Of Daily Trading Volume S

^{Published on 2009-09-02 09:08:32, Last Modified on 2010-12-22 14:42:39 - WOPRAI}
 

September 2, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Tuesday, September 1st, 2009 and come to the following statistical conclusions. There were 6,709 stocks with daily short volume reported and total NASDAQ trading volume of 1,586,749,500 shares. Total Daily Short Volume was 772,337,291 shares. 48.67% of all trading on the NASDAQ Tuesday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Metabasis Therapeutics (NASDAQ: MBRX), Crosstex Energy (NASDAQ: XTXI), Inspire Pharmaceuticals (NASDAQ: ISPH), Grand Canyon Education (NASDAQ: LOPE), Smith Micro Software (NASDAQ: SMSI) and Zebra Technologies (NASDAQ: ZBRA). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20090901 MBRX 93,928 123,946 Q 75.78%

20090901 XTXI 103,852 140,517 Q 73.91%

20090901 ISPH 378,182 512,188 Q 73.84%

20090901 LOPE 99,693 135,865 Q 73.38%

20090901 SMSI 107,856 147,552 Q 73.10%

20090901 ZBRA 90,441 124,342 Q 72.74%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa� naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Metabasis Therapeutics, Inc. (NASDAQ: MTBX), a biopharmaceutical company, engages in the discovery, development, and commercialization of novel drugs targeting the liver and liver pathways. Its product pipeline includes clinical-stage product candidates and advanced discovery programs for the treatment of metabolic diseases, such as diabetes and hyperlipidemia. The companya�s product candidates under development comprise MB07811, which is in Phase II clinical trials for the treatment of hyperlipidemia; and MB07803, which is in Phase II clinical trials for the treatment of type 2 diabetes. Its metabolic disease advanced discovery programs consist of AMPK, a metabolic disease program focusing on the development of drug candidates for the treatment of type 2 diabetes and other metabolic diseases; Glucagon Antagonist, a program focusing on identifying orally bioavailable glucagon antagonists for the treatment of type 2 diabetes; and TR agonist, a second-generation program to identify drug candidates for the treatment of hyperlipidemia. It has collaborative research and development agreements with Roche; Merck & Co.; Idenix Pharmaceuticals, Inc.; Daiichi Sankyo Company, Ltd.; Valeant Pharmaceuticals International; and Schering Corporation. The company was founded in 1997 and is based in La Jolla, California.

Crosstex Energy, Inc. (NASDAQ: XTXI), through its partnership interest in Crosstex Energy, L.P., engages in gathering, transmission, treating, processing, and marketing natural gas and natural gas liquids (NGLs) in the United States. The company connects the wells of natural gas producers in its market areas to its gathering systems; treats natural gas to remove impurities; processes natural gas for the removal of NGLs; fractionates NGLs into purity products; and transports natural gas to various markets. It also purchases natural gas from natural gas producers and other supply points; and sells that natural gas to utilities, industrial consumers, other marketers, and pipelines. In addition, it operates processing plants that process gas transported to the plants by interstate pipelines or from its own gathering systems. Further, the company purchases natural gas from producers not connected to gathering systems for resale and sells natural gas on behalf of producers. As of December 31, 2008, it operated approximately 5,700 miles of natural gas gathering and transmission pipelines, 12 natural gas processing plants, 4 fractionators, and 200 treating and dew point control plants. The company was founded in 1996 and is based in Dallas, Texas.

Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH), a biopharmaceutical company, engages in researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The company offers AzaSite, an azithromycin ophthalmic solution and topical anti-infective; Elestat, an epinastine HCl ophthalmic solution and topical antihistamine for the prevention of ocular itching associated with allergic conjunctivitis; and Restasis, a cyclosporine ophthalmic emulsion for the treatment of dry eye disease in adults and children in the United States. Its product candidates in clinical development include Prolacria, a diquafosol tetrasodium for the treatment of dry eye disease in phase III; denufosol tetrasodium, an inhaled product for the treatment of cystic fibrosis in phase III; AzaSite for the treatment of blepharitis, which is in phase II; and INS115644 and INS117548, which are in phase I clinical trial for the treatment of glaucoma or ocular hypertension. The company has a joint license agreement with Allergan, Inc. to develop and commercialize Prolacria; a license agreement with InSite Vision Incorporated to commercialize AzaSite, as well as other topical anti-infective products containing azithromycin used in the treatment of human ocular or ophthalmic indications primarily in the U.S. and Canada; and a development, license, and supply agreement with Santen Pharmaceutical Co., Ltd. for the development of diquafosol tetrasodium for the therapeutic treatment of ocular surface diseases in Asia. Inspire Pharmaceuticals was founded in 1993 and is based in Durham, North Carolina.

Grand Canyon Education, Inc. (NASDAQ: LOPE) provides online postsecondary education services in the United States. It focuses on offering graduate and undergraduate degree programs in education, business, and healthcare disciplines. The company also offers ground and onsite programs. As of December 31, 2008, it enrolled approximately 24,600 students. The company was formerly known as Significant Education, Inc. and changed its name to Grand Canyon Education, Inc. in May 2008. Grand Canyon Education, Inc. was founded in 1949 and is based in Phoenix, Arizona.

Smith Micro Software, Inc. (NASDAQ: SMSI) develops and markets mobile software products and services. The companys wireless software products and services include the QuickLink family of desktop and mobile products to manage wireless data communications, including software applications for broadband mobile networks, Wi-Fi, personal information management, mobile content management, device management, and data compression solutions. It offers QuickLink Mobile, QuickLink Mobility, and QuickLink Server wireless products for the connection management application to control, customize, and automate various wireless connections; QuickLink PhoneManager, which includes connectivity and device management server for the management of software and firmware update; and QuickLink Music and QuickLink Media, which are music and multimedia manager products that sync digital content to and from mobile devices. The company also provides StuffIt Wireless that enables compression of data files to facilitate storage in mobile devices and transmission over wireless network; Insignia Device Management suite to manage a range of mobile devices, including mobile phones and PDAs, as well as offers other wireless products, such as the QuickLink Voice and Messenger, and Active Images. In addition, it offers consumer products, including StuffIt Deluxe, StuffIt Mobile, CheckIt Registry Cleaner, Spring Cleaning, Internet Cleanup, Executive Synch, Poser, Anime Studio, Manga Studio, and Aquazone that provides utility and diagnostic solutions, and graphics products. Further, the company distributes third party Mac and Windows PC software products through its online stores and third-party wholesalers. It serves wireless service providers, OEMs, PC and device manufacturers, enterprise businesses, and consumers. The company markets its products and services through direct and indirect sales distribution channels. The company was founded in 1982 and is headquartered in Aliso Viejo, California.

Zebra Technologies Corporation (NASDAQ: ZBRA) designs and manufactures products and solutions to identify, track, and manage assets, transactions, and people. The companya�s Specialty Printing Group segment provides specialty printing devices that print variable information on demand at the point of issuance. Its products include direct thermal and thermal transfer label printers, radio frequency identification printer/encoders, dye sublimation card printers, digital photo printers, and related accessories and support software. This segment offers its printers to produce bar code labels, passive RFID labels, receipts, plastic identification cards, wristbands, and tags; printer supplies products comprising stock and customized thermal labels, wristbands, smart labels and tags, plastic cards, card laminates, and thermal transfer ribbons; printer management, label design, and driver solutions; and depot maintenance and repair services. Its products are used for various applications in inventory control, small package delivery, baggage handling, automated warehousing, just-in-time manufacturing, employee time and attendance records, file management systems, hospital information systems, medical specimen labeling, shop floor control, in-store product labeling, employee ID cards, drivera�s licenses, and access control systems. This segment provides its products to manufacturers, service organizations, and governments worldwide through distributors, value-added resellers, and original equipment manufacturers, as well as through the Internet and telesales operations. The Enterprise Solutions Group segment offers asset tracking and management solutions for the aerospace and defense, aviation, automotive, industrial manufacturing, maritime, and transportation and logistics industries, as well as provides maintenance, support, and consulting services. This segment also sells real time asset management hardware. The company was founded in 1991 and is headquartered in Lincolnshire, Illinois.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net